Tsai, M.-C.; Huang, C.-C.; Wei, Y.-C.; Liu, T.-T.; Lin, M.-T.; Yi, L.-N.; Lin, P.-R.; Wang, C.-C.; Chu, T.-H.; Hsiao, C.-C.;
et al. Combined Chibby and β-Catenin Predicts Clinical Outcomes in Patients with Hepatocellular Carcinoma. Int. J. Mol. Sci. 2020, 21, 2060.
https://doi.org/10.3390/ijms21062060
AMA Style
Tsai M-C, Huang C-C, Wei Y-C, Liu T-T, Lin M-T, Yi L-N, Lin P-R, Wang C-C, Chu T-H, Hsiao C-C,
et al. Combined Chibby and β-Catenin Predicts Clinical Outcomes in Patients with Hepatocellular Carcinoma. International Journal of Molecular Sciences. 2020; 21(6):2060.
https://doi.org/10.3390/ijms21062060
Chicago/Turabian Style
Tsai, Ming-Chao, Chao-Cheng Huang, Yu-Ching Wei, Ting-Ting Liu, Ming-Tsung Lin, Li-Na Yi, Pey-Ru Lin, Chih-Chi Wang, Tian-Huei Chu, Chang-Chun Hsiao,
and et al. 2020. "Combined Chibby and β-Catenin Predicts Clinical Outcomes in Patients with Hepatocellular Carcinoma" International Journal of Molecular Sciences 21, no. 6: 2060.
https://doi.org/10.3390/ijms21062060
APA Style
Tsai, M.-C., Huang, C.-C., Wei, Y.-C., Liu, T.-T., Lin, M.-T., Yi, L.-N., Lin, P.-R., Wang, C.-C., Chu, T.-H., Hsiao, C.-C., Hu, T.-H., & Tai, M.-H.
(2020). Combined Chibby and β-Catenin Predicts Clinical Outcomes in Patients with Hepatocellular Carcinoma. International Journal of Molecular Sciences, 21(6), 2060.
https://doi.org/10.3390/ijms21062060